郭曼岚;漆敏;刘蔚雯;勾梦壮;孙密欣;刘亚伟;陈腾祥;
GUO Manlan;QI Ming;LIU Weiwen;GOU Mengzhuang;SUN Mixin;LIU Yawei;CHEN Tengxiang;Department of Physiology,Basic Medicine College,Guizhou Medical University;Laboratory for Precision Neurosurgery,Nanfang Hospital,Southern Medical University;First College of Clinical Medicine,Southern Medical University;The Key Laboratory of Regenerative Medicine of Guizhou Province,Guizhou Medical University;

• 1:贵州医科大学基础医学院生理学教研室
• 2:南方医科大学南方医院神经外科精准神经外科实验室
• 3:南方医科大学第一临床医学院
• 4:贵州医科大学贵州省再生医学重点实验室

摘要(Abstract)：

目的:观察雷公藤甲素(Tp)对人结肠癌细胞EKR1/2、Akt、p53及AMPKα等信号通路分子的影响。方法:体外培养人结肠癌SW480细胞,用40 nmol/L Tp刺激24 h,分别于刺激0、24 h时对细胞进行拍照,观察细胞形态,应用Path Scan分别检测细胞内信号通路分子ERK1/2的Thr202/Tyr204位点、Akt的Thr308和Ser473位点,AMPKα的Thr172位点及p53的Ser15位点的磷酸化水平,并通过Western blot验证p53蛋白在人结肠癌细胞SW480,SW620和HCT116细胞中的磷酸化水平。结果:40 nmol/L Tp刺激24 h后,人大肠癌SW480细胞变大、形态不规整、触角变长,细胞表型发生改变;Path Scan结果表明,Tp刺激24 h时,SW480细胞ERK1/2的Thr202/Tyr204位点、Akt的Thr308和Ser473位点及p53的Ser15位点磷酸化水平增高,AMPKα的Thr172磷酸化水平降低;Western blot实验结果显示,Tp刺激24 h时,人结肠癌SW480、SW620和HCT116细胞中p53蛋白的磷酸化水平上调。结论:Tp可能是通过ERK1/2、Akt、p53和AMPKα信号通路影响结肠癌细胞表型改变。
Objective: To observe the effects of triptolide( Tp) on the phosphorylation of intracellular signaling pathway molecules in human colorectal cancer cells EKR1/2,Akt,p53,and AMPKα.Methods: Human colorectal cancer SW480 cells were cultured in vitro and stimulated by 40 nmol/L Tp for 24 h. Path Scan assay was used to detect the phosphorylation of intracellular signaling pathway molecules in ERK1/2 at Thr202/Tyr204,Akt at Thr308/Ser473,AMPKα at Thr172 and p53 at Ser15. The phosphorylation of p53( Ser15) in SW480,SW620 and HCT116 cells were verified by Western blot. Results: The cellular morphology during the treatment with 40 nmol/L Tp for 24 h observed by the microscope showed significant changes. Path Scan method detected some important molecules in ERK1/2,Akt,p53 and AMPKα which were activated by phosphorylation within the intracellular signaling pathways. Western blot demonstrated that the level of p-p53( Ser15) was up-regulated in SW480,SW620 and HCT116 cells of human colorectal cancer. Conclusions: Triptolide,Tp can change the phenotype of colorectal cancer cells,which is likely to be developed through activation of ERK1/2,Akt,p53,and AMPKα in signaling pathways.

关键词(KeyWords)： 雷公藤甲素;结肠肿瘤;p53;ERK1/2;体外培养;SW480细胞
triptolide;colorectal cancer;p53;ERK1/2;culture in vitro;SW480 cells

Abstract:

Keywords:

基金项目(Foundation): 广东省自然科学基金(2017A030313497);; 贵州省应用基础研究计划重大专项子课题[黔科合J重大字(2015)2003]

作者(Author): 郭曼岚;漆敏;刘蔚雯;勾梦壮;孙密欣;刘亚伟;陈腾祥;
GUO Manlan;QI Ming;LIU Weiwen;GOU Mengzhuang;SUN Mixin;LIU Yawei;CHEN Tengxiang;Department of Physiology,Basic Medicine College,Guizhou Medical University;Laboratory for Precision Neurosurgery,Nanfang Hospital,Southern Medical University;First College of Clinical Medicine,Southern Medical University;The Key Laboratory of Regenerative Medicine of Guizhou Province,Guizhou Medical University;

Email:

DOI: 10.19367/j.cnki.1000-2707.2018.04.010

参考文献(References)：

• [1]SIEGEL R L,MILLER K D,JEMAL A.Cancer statistics,2016[J].CA:A Cancer Journal for Clinicians,2016,66(1):7-30.
• [2]CHEN W,ZHENG R,ZHANG S,et al.The incidences and mortalities of major cancers in China,2009[J].Chin J Cancer,2013,32(3):106-112.
• [3]SONG L P,WANG H Y.Modeling and control of colorectal cancer[J].PLo S One,2016,11(8):e161349.
• [4]RENTSCH M,SCHIERGENS T,KHANDOGA A,et al.Surgery for colorectal cancer-trends,developments,and future perspectives[J].Visc Med,2016,32(3):184-191.
• [5]ZHANG Y,CHEN Z,LI J.The current status of treatment for colorectal cancer in China:A systematic review[J].Medicine(Baltimore),2017,96(40):e8242.
• [6]KUPCHAN S M,COURT W A,DAILEY R J,et al.Triptolide and tripdiolide,novel antileukemic diterpenoid triepoxides from tripterygium wilfordii[J].J Am Chem Soc,1972,94(20):7194-7195.
• [7]CUI J,CHEN X,SU J C.Advanced progress of main pharmacology activities of triptolide[J].Zhongguo Zhong Yao Za Zhi,2017,42(14):2655-2658.
• [8]HO L J,CHANG W L,CHEN A,et al.Differential immunomodulatory effects by Tripterygium wilfordii Hook fderived refined extract PG27 and its purified component PG490(triptolide)in human peripheral blood T cells:potential therapeutics for arthritis and possible mechanisms explaining in part Chinese herbal theory"JunnChenn-Zuou-SS"[J].J Transl Med,2013,11(3):294.
• [9]PATIL S,LIS L G,SCHUMACHER R J,et al.Phosphonooxymethyl prodrug of triptolide:Synthesis,physicochemical characterization,and efficacy in human colon adenocarcinoma and ovarian cancer xenografts[J].J Med Chem,2015,58(23):9334-9344.
• [10]TAMGUE O,LEI M.Triptolide promotes senescence of prostate cancer cells through histone methylation and heterochromatin formation[J].Asian Pac J Cancer Prev,2017,18(9):2519-2526.
• [11]JIANG C,FANG X,ZHANG H,et al.Triptolide inhibits the growth of osteosarcoma by regulating microRNA-181a via targeting PTEN gene in vivo and vitro[J].Tumour Biol,2017,39(4):560-568.
• [12]LIU Y,SONG F,WU W K K,et al.Triptolide inhibits colon cancer cell proliferation and induces cleavage and translocation of 14-3-3 epsilon[J].Cell Biochemistry and Function,2012,30(4):271-278.
• [13]郭伟健,何敏毅,孙学刚,等.雷公藤甲素对大肠癌细胞细胞周期的调控作用[J].贵阳医学院学报,2012(2):141-144.
• [14]FEITELSON M A,ARZUMANYAN A,KULATHINAL R J,et al.Sustained proliferation in cancer:Mechanisms and novel therapeutic targets[J].Seminars in Cancer Biology,2015,35:S25-S54.
• [15]ROSKOSKI R J.ERK1/2 MAP kinases:Structure,function,and regulation[J].Pharmacol Res,2012,66(2):105-143.
• [16]SU C H,W WANG C Y,LAN K H,et al.Akt phosphorylation at Thr308 and Ser473 is required for CHIP-mediated ubiquitination of the kinase[J].Cell Signal,2011,23(11):1824-1830.
• [17]WANG L,BRAUTIGAN D L.alpha-SNAP inhibits AMPK signaling to reduce mitochondrial biogenesis and dephosphorylates Thr172 in AMPKalpha in vitro[J].Nat Commun,2013,4(6):1559.
• [18]LOUGHERY J,COX M,SMITH L M,et al.Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters[J].Nucleic Acids Res,2014,42(12):7666-7680.
• [19]CITI V,DEL R M,MARTELLI A,et al.Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro[J].Cancer Chemother Pharmacol,2018,81(4):1-10.
• [20]CICENAS J.The potential role of Akt phosphorylation in human cancers[J].Int J Biol Markers,2008,23(1):1-9.
• [21]QIAO M,SHENG S,PARDEE A B.Metastasis and AKT activation[J].Cell Cycle,2008,7(19):2991-2996.
• [22]VINCENT E E,ELDER D J,THOMAS E C,et al.Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer[J].Br J Cancer,2011,104(11):1755-1761.
• [23]CHUNHUA L,DONGLAN L,XIUQIONG F,et al.Apigenin up-regulates transgelin and inhibits invasion and migration of colorectal cancer through decreased phosphorylation of AKT[J].J Nutr Biochem,2013,24(10):1766-1775.
• [24]ZHANG W B,WANG Z,SHU F,et al.Activation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and m TORC1 inhibition[J].J Biol Chem,2010,285(52):40461-40471.
• [25]NIEMINEN A I,ESKELINEN V M,HAIKALA H M,et al.Myc-induced AMPK-phospho p53 pathway activates Bak to sensitize mitochondrial apoptosis[J].Proc Natl Acad Sci U S A,2013,110(20):1839-1848.
• [26]INOKI K,ZHU T,GUAN K L.TSC2 mediates cellular energy response to control cell growth and survival[J].Cell,2003,115(5):577-590.
• [27]KIM J,KUNDU M,VIOLLET B,et al.AMPK and m TOR regulate autophagy through direct phosphorylation of Ulk1[J].Nat Cell Biol,2011,13(2):132-141.
• [28]WU W D,HU Z M,SHANG M J,et al.Cordycepin down-regulates multiple drug resistant(MDR)/HIF-1alpha through regulating AMPK/m TORC1 signaling in GBC-SD gallbladder cancer cells[J].Int J Mol Sci,2014,15(7):12778-12790.
• [29]VAZQUEZ-MARTIN A,LOPEZ-BONET E,OLIVERASFERRAROS C,et al.Mitotic kinase dynamics of the active form of AMPK(phospho-AMPKalpha Thr172)in human cancer cells[J].Cell Cycle,2009,8(5):788-791.
• [30]ZHENG H,CHEN L,PLEDGER W J,et al.p53 promotes repair of heterochromatin DNA by regulating JMJD2b and SUV39H1 expression[J].Oncogene,2014,33(6):734-744.
• [31]STEGH A H.Targeting the p53 signaling pathway in cancer therapy-the promises,challenges and perils[J].Expert Opin Ther Targets,2012,16(1):67-83.
• [32]MULLER P A,VOUSDEN K H.p53 mutations in cancer[J].Nat Cell Biol,2013,15(1):2-8.
• [33]DUFFY M J,SYNNOTT N C,MCGOWAN P M,et al.p53 as a target for the treatment of cancer[J].Cancer Treat Rev,2014,40(10):1153-1160.
• [34]LI W,LIU Y,LI X X,et al.MAPKs are not involved in triptolide-induced cell growth inhibition and apoptosis in prostate cancer cell lines with different p53 status[J].Planta Med,2011,77(1):27-31.
• [35]ZHAO F,HUANG W,OUSMAN T,et al.Triptolide induces growth inhibition and apoptosis of human laryngocarcinoma cells by enhancing p53 activities and suppressing E6-mediated p53 degradation[J].PLo S One,2013,8(11):e80784.
• [36]ZHENG L,JIA J,DAI H,et al.Triptolide-assisted phosphorylation of p53 suppresses inflammation-induced NF-kappa B survival pathways in cancer cells[J].Mol Cell Biol,2017,37(15):1128-1134.

文章评论(Comment)：